Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALGRX 3268 for procedural pain in pediatric patients
NCT00140088Phase 3Completed
- Sponsor
- AlgoRx Pharmaceuticals
- Start
- Dec 2004
- Modality
- Device-based Delivery, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in procedural pain comparing ALGRX 3268 with Placebo (2 arms). Primary endpoint: Wong-Baker FACES Pain Rating Scale. Started Dec 2004; status: completed.
02
Drugs
ALGRX 3268
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT00140088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00140088.